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The development of tools for the genetic manipulation of 
the causative agents of malaria - protozoan parasites of 
the genus Plasmodium - has been arduous and frus-
tratingly slow. The drive to obtain such tools is motivated 
by the ongoing public-health significance of this disease - 
malaria remains a global health and economic catas-
trophe for which new drugs and an effective vaccine are 
desperately needed, and if these are to be rationally 
designed, new insights into Plasmodium biology, particu-
larly in understanding the function of individual gene 
products, are in turn required. An illustration of this is 
provided by the new vaccine candidates that are arising 
from studies identifying specific parasite antigens as 
essential or important for red blood cell invasion. 
Manipulation of the genes encoding these candidates was 
key to dissecting the relative importance and the precise 
nature of their biological roles [1]. However, progress in 
this and related endeavors has been slow, because genetic 
manipulation of Plasmodium parasites remains labor-
ious. Indeed two issues in particular have dogged efforts 
to develop a array of robust tools to analyze gene function 
in Plasmodium: (1) low transformation efficiency where-
by very few parasites in a population receive DNA during 
an individual transfection experiment, and (2) an inability 
to use RNA interference approaches (which is an alterna-
tive to traditional transformation methods) because the 
specific RNAi machinery is lacking in this organism [2].
Nevertheless, steady progress is being made and a 
range of molecular genetic approaches to dissect the 
function of the 5,300 or so Plasmodium genes - including 
transgenesis, gene knockout, site-directed mutagenesis 
and knockdown of gene expression - are now available 
and have been used to good effect [3]. Such tools have 
been developed both in Plasmodium falciparum, the 
main cause of human malaria, and in the rodent model 
system Plasmodium berghei. In fact the development of 
tools for investigating P. berghei has often outpaced that 
for P. falciparum, largely because of the greater efficiency 
with which plasmid DNA can be introduced in this 
organism. Apart from P. berghei’s greater tractability to 
genetic manipulation, this model has much to offer 
because the entire life cycle - through blood, insect-borne 
and liver stages - can be readily completed in an experi-
mental setting. This is much more difficult to achieve in 
any non-rodent system. Because many genes are shared 
across Plasmodium species and are considered ortholo-
gous, dissection of gene function in P. berghei can be 
hugely informative to human malaria biology.
Two major obstacles remain in the development of 
molecular genetic tools for Plasmodium species: the lack 
of a simple but robust system to conditionally ablate the 
function of genes essential to the blood-stage cycle and 
the lack of a highly efficient random mutagenesis system 
to allow classical forward genetic screens to recover 
mutants with interesting phenotypes. A paper by Fonager 
et al. [4] in BMC Genomics has made great strides in 
address ing the second of these obstacles.
What’s new?
Fonager and colleagues [4] have developed a system that 
introduces the piggyBac transposon into the genome of P. 
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berghei. Originally recognized in virus-infected insect 
cells, piggyBac has been developed as a tool for insertion 
mutagenesis in a wide range of systems, including 
mammalian cells. DNA elements flanked by piggyBac 
sequences can insert into TTAA sequences throughout 
any genome, as long as the cells also express the piggyBac 
transposase, the enzyme required for piggyBac trans-
position (Figure 1).
Fonager et al. [4] build on earlier successes in the 
Adams laboratory using the same transposon to mutate 
P. falciparum [5,6]. What is new in the current study, 
apart from the fact that the system has been modified for 
P. berghei, is the markedly improved efficiency of inser-
tion, some 16-18 times that seen in P. falciparum. In the 
P. berghei system, 50 or more insertion events can be 
achieved in a single transfection. Moreover, integration 
was encouragingly random and included frequent inte-
gration into coding sequences, which was not commonly 
seen in P. falciparum. This approach can there fore be 
used to disrupt gene expression (see Figure 1), and the 
authors demonstrate targeting by piggyBac of genes for 
proteins non-essential to blood-stage growth [4].
Another advance described is the stable integration of 
the transposase gene into the genome of P. berghei. The 
consequent continuous expression of the transposase 
allows excision of an integrated piggyBac element and its 
reinsertion at another genomic location, thus increasing 
the potential coverage of transposon insertion resulting 
Figure 1. Use of the piggyBac transposon system to disrupt gene function and ‘trap’ promoter elements. The piggyBac transposase encoded 
by the pHTH plasmid can integrate a gene cassette (carried on the pBAC-BACII-GFP-hDHFR plasmid) flanked by piggyBac-specific inverted repeats 
into random TTAA sites within the P. berghei genome [4]. The gene cassette contains a promoter-less green fluorescent protein (gfp) gene and a 
human dihydrofolate reductase (hdhfr) selectable marker. The function of P. berghei genes can be ablated by disrupting their coding sequences or 
their promoters by insertion of the gfp-hdhfr cassette. If the cassette inserts downstream of a gene promoter (as shown here) this promoter can 
drive expression of gfp, which provides information about the timing of expression of the disrupted gene.
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from a single transfection experiment [4]. Together, these 
features mean that screening for genes responsible for 
particular phenotypes is now more feasible and 
practicable in Plasmodium parasites. Demonstrating the 
potential for such ‘forward genetic’ screens, Fonager et 
al. [4] show that it is possible to identify transcriptional 
promoters in the P. berghei genome by ‘trapping’ a 
promoter-less green fluorescent protein marker gene 
flanked by piggyBac elements downstream of a functional 
promoter (Figure 1).
Where to now?
So what is the potential of the piggyBac mutagenesis 
system for genome-wide screens in P. berghei? For 
example, will it be possible to identify at a genome-wide 
level all the genes essential, or dispensable, for blood-
stage growth? To date, several medium-scale gene-
knock out approaches have been published, obtaining 
20-80 gene-targeting events per study [7,8]. These pro-
grams were enormously labor intensive, however, and fall 
far short of the genome-wide knockouts needed.
Another question to be asked of any new technique is 
can it identify the gene(s) responsible for a measurable 
phenotype, the genetic equivalent of finding a needle in 
haystack. Such forward genetic screens are particularly 
needed for Plasmodium parasites, in which nearly 50% of 
Plasmodium genes have no recognizable orthologs out-
side the genus, as no previous knowledge about gene 
function is required [9]. In forward genetic screens in 
model organisms, genomes are generally randomly 
mutated by radiation, chemical mutagens or insertional 
mutagenesis using transposons, after which mutants are 
identified by phenotypic assay and the phenotype tied 
back to the gene that has been mutated. Such approaches 
require mutagenesis at a ‘saturation’ level where every 
gene is perturbed in a single experiment. While some 
progress has been made in achieving insertional muta-
genesis in Plasmodium, the systems developed to date to 
not approach the ‘saturation’ levels required.
It is probably fair to say that even with the improved 
efficiency of piggyBac insertion demonstrated by Fonager 
et al. [4], this system still falls short of a ‘saturating’ 
mutagenesis procedure that could be easily used for 
screens. The authors estimate that up to 50 transfection 
experiments would need to be performed to achieve this 
level of integration. Most promise for the future probably 
lies in further improvements to the re-mobilization 
approach demonstrated by Fonager et al., in which the 
transposase remains expressed in the parasite cell and 
facilitates the transposition of piggyBac from one inser-
tion site to another. More frequent and controllable re-
mobilization is probably required to make such an 
approach effective in achieving frequent insertion events. 
Perhaps this could be achieved by higher-level expression 
of the transposase and by controlling expression of the 
transposase with a conditionally regulatable system. 
Several methods for doing this are now emerging.
Because parasites are grown and transfected in the 
haploid blood-stages, the piggyBac insertion approach 
will, unfortunately, only be useful for the functional 
analysis of genes that are not essential to blood-stage 
survival, that is, it will not be possible to recover mutants 
in which piggyBac has inserted into genes that have a role 
in blood-stage development. The very essentiality of 
these genes is of particular interest, as they are likely to 
be the best targets for future drugs and vaccines. To 
investigate essential genes will require combining the 
piggyBac system with one of the conditional expression 
systems currently available. One possibility would be to 
place the anhydrotetracycline (ATc)-regulated gene-
expression system within the piggyBac inverted terminal 
repeats [3], allowing the piggyBac-flanked ATc-regulated 
promoter to jump into and replace the promoter of a 
random gene. The ATc-regulated promoter would be in 
the switched-on state, in case the downstream random 
gene is essential. Once parasites containing these inserted 
promoters have been cloned, the addition of ATc would 
switch off expression of the targeted gene, producing a 
rapid and observable phenotype if the gene is essential.
In summary, this work in P. berghei [4] builds on the 
less efficient piggyBac mutagenesis system developed for 
P. falciparum and provides a clear path for saturating 
genome-wide mutagenesis to be achieved in this 
organism. Such approaches are needed if the huge 
amount of genomic information now available is to be 
dissected and exploited to produce new tools for malaria 
control. This need is as urgent as ever, given the 
continued lack of a licensed malaria vaccine and concern 
over the emergence of parasite strains tolerant to 
artemisinin derivatives [10].
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